HK2; D1R; kidney; Gq/11␣; Gi␣ CELLS FROM DIFFERENT ORGAN tissues such as the brain, liver, and kidney have been immortalized and passaged many times to grow in cultures, providing the opportunity to avoid organ tissue complexity and yet study cellular physiology. For example, CATH.a cells are derived from the mouse locus coeruleus brain region and are used in examining cellular pathways involved in the anxiety response (25) . HepG2 is a human liver-derived cell line which is utilized for examining the insulin signaling pathway (19) . Madin-Darby canine kidney (MDCK) and LLC-PK cells are derived from dog and porcine kidneys, respectively. MDCK and LLC-PK cell lines are nephron segment specific, representing cells from distal and proximal tubules, respectively (7, 15) , enabling the study of nephron segment-specific renal physiology in cultures.
Studying a cell line of human origin over a nonhuman source has translational value. HK2 is a human kidney cell line of proximal tubular origin but has been reported to harbor a nonfunctional dopamine D1 receptor (D1R) (13) , suggesting that these cells cannot be used to study D1R physiology in cultures. Dysfunction of D1R in HK2 cells is reported to be due in part to inability of the receptor to couple to Gs protein, stimulate adenylate cyclase-mediated cAMP accumulation, and inhibit the Na/H exchanger (13) . D1R in renal proximal tubules also couples to another class of G protein, namely Gq, activates PKC, and inhibits Na-K-ATPase (6, 11, 12, 18, 27) . These are two major pathways in renal proximal tubules that help maintain sodium homeostasis and blood pressure (16, 17) .
In view of the above, we wanted to test whether HK2 cells can still be used as a tool for studying D1R physiology. We hypothesized that despite aberrant D1R-Gs signaling as reported by Gildea et al. (13) , D1R-Gq signaling is intact in HK2 cells. In addition, we designed experiments to study D1R coupling to G proteins (by 35 S-GTP␥S binding assay) and the surrogate marker of Gq signaling, namely PKC and Na-KATPase activities. Some of the findings related to D1R-Gq signaling were corroborated by studying another receptor, the ANG II AT1 receptor (AT1R), known to couple to Gq protein and activate PKC (21) . Regulation of specific PKC isoforms (␣, ␤, ␦, ε, , and ) by D1R and AT1R is linked to the inhibition of Na-K-ATPase (3, 20, 22, 29) . Additionally, we also determined the response of fenoldopam (FD) on cAMP accumulation, a marker of D1R coupling to Gs, in HK2 cells.
MATERIALS AND METHODS
Cell cultures. Human kidney epithelial cells (HK2 cells) of proximal tubular origin, expressing proximal tubular marker Na/H exchanger-3 (NHE3) (Fig. 1A) , were obtained from ATCC (Manassas, VA) and cultured in DMEM/F12 supplemented with epidermal growth factor (10 ng/l), pituitary hormone (15 g/ml), and bovine serum (10%; vol/vol). Cells were maintained at 37°C under 5% CO 2 and passaged at 80 -90% confluence. Cells from passages 6 -15 were used in the study.
Drug treatments. All drug treatments were carried out in 80% confluent cells starved overnight in DMEM/F12 medium without serum and the supplements, bovine pituitary hormone and epidermal growth factor. FD, a D1-like receptor (D1R/D5R) agonist (1 M, 10 min), and ANG II (1 M, 10 min) treatments were carried out in cells with prior treatment without (vehicle) and with the D1-like receptor (D1R/D5R) antagonist SCH 23390 (1 M, 15 min), chelerythrine chloride, which targets the catalytic domain and inhibits membrane translocation of PKC (9, 14) , the Gi inhibitor pertussis toxin (100 ng/ml, 15 min), and the AT1R blocker candesartan (1 M, 15 min) as needed. Control cells were treated with vehicle while phorbol ester (PMA, 1 M, 10 min) was used as a direct activator of PKC to treat the cells.
cAMP assay. Cells (80% confluent) were pretreated with the phosphodiesterase inhibitor IBMX (100 M, 15 min) followed by treatment with vehicle and FD (1 M, 10 min). FD treatment was carried out in the absence and presence of the D1R/D5R antagonist SCH23390. Prior treatment of SCH23390 (1 M, 15 min) was carried out before the addition of FD. Forskolin (10 M, 10 min) by activating adenylate cyclase causes cAMP accumulation, which was a positive control in the study. A kit-based ELISA method was used to determine cAMP levels following the manufacturer's instructions (Cayman Chemical, Ann Arbor, MI).
Small interfering RNA transfection. Custom small interfering (si) RNA for Gq/11␣ (sense: GGGUAUCGACGAUUACAAAUU, antisense: UUGUAAUCGUCGAUACCCUG) and All Star negative control siRNA were obtained from Qiagen (Valencia, CA). Transfections were performed in 50% confluent cells with 40 -200 nM siRNA for 24 -48 h using Fugene 6 Transfection reagent (Roche Applied Science, Indianapolis, IN) following the manufacturer's instructions. Treatment with 200 nM Gq/11␣ siRNA but not control siRNA for 48 h maximally depleted cellular Gq/11␣ protein levels (Fig. 1B) . Thereafter, cells transfected with control and Gq/11␣ siRNA for 48 h were used in subsequent experiments.
PKC activity. Cells were lysed in lysis buffer (20 mM Tris·HCl, pH 7.5, 150 mM NaCl, 1 mM Na 2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM ␤-glycerophosphate, 1 mM sodium orthovanadate, 1 g/ml leupeptin). Protein concentration was determined by the BCA method. An ELISA-based method (10) was used to determine PKC activity in the cellular homogenate (15 g) using a commercially available kit (Enzo Life Sciences, Farmingdale, NY) by following the manufacturer's instructions.
Na-K-ATPase ( 86 rubidium uptake) activity. 86 Rubidium ( 86 Rb) uptake is an index of potassium uptake and determines Na-K-ATPase activity when total 86 Rb uptake (without ouabain) is subtracted from the 86 Rb uptake in presence of ouabain, a specific Na-K-ATPase-␣1 inhibitor. 86 Rb uptake was carried out using our method (2) with minor modifications. Briefly, 5 ϫ 10 6 cells were seeded in six-well plates, grown to 80% confluence, and starved overnight (no serum and supplements). Thereafter, cells were treated with EGTA (10 mM, 1 h, 37°C) followed by treatment with monensin (5 M, 1 h, 37°C). After washing with PBS, cells were treated without and with ouabain (2 mM) for 10 min at room temperature. Rubidium uptake was initiated with radioactive rubidium (3 Ci/ml) and followed for 5 min. The uptake was terminated by washing the cells three times with chilled PBS. The cells were lysed in lysis buffer (400 l) as above and counted for radioactivity (350 l) on a gamma counter (PerkinElmer, Waltham, MA). The rest of the sample was used to measure protein. Different drug incubations (mentioned above) were carried out after ouabain treatment and before the initiation of 86 Rb uptake. Membrane preparations. Cells were homogenized with a dounce homogenizer in ice-cold sucrose buffer (pH 7.4, 10 mM Tris, 250 mM sucrose, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, 1 mM ␤-glycerophosphate, 1 mM PMSF, 1ϫ protease inhibitor cocktail, Roche Applied Science, Indianapolis, IN), and centrifuged (18,000 rpm for 35 min at 4°C). The membranous pellet was washed in the same buffer (18,000 rpm for 10 min at 4°C) and resuspended in 50 l of sucrose buffer and passed through a 23/27-G needle for a homogeneous suspension. An aliquot (5 l) of the sample was used for protein estimation, and the rest was utilized for 35 S-GTP␥S binding studies, Western blotting, and coimmunoprecipitation assays.
S-GTP␥S binding.
35 S-GTP␥S (0.6 nM, ϳ100,000 cpm, Perkin Elmer, Waltham, MA) binding in the absence and presence of FD and ANG II was performed in the cellular membranes by our published method (10) . Briefly, assays were performed in 96-well multiscreen filter plates (EMD Millipore, Billerica, MA) containing 5 g of membrane protein and 35 S-GTP␥S in an assay buffer (100 l final volume, 25 mM HEPES, 15 mM MgCl 2, 100 mM NaCl, 1 mM EDTA, 1 mM DTT, and 1 M GDP). The plate was incubated at 30°C for 60 min with occasional shaking, the reaction was stopped by filtration, and the filters were washed four to five times with ice-cold assay buffer. The filter paper was carefully removed from the wells, dried in a vial, and radioactivity was counted by liquid scintillation fluid on a liquid scintillation counter (6500 Beckman counter).
Coimmunoprecipitation. All the steps were carried out at 4°C (unless otherwise mentioned). Cellular membranes (1.5 mg/ml) were resuspended in immunoprecipitation (IP) buffer [50 mM Tris·HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF, 1% Triton X 100, 1ϫ protease inhibitor cocktail] and incubated with 100 l protein A/G agarose beads (prewashed in IP buffer) for 30 min with end-to-end (EOE) shaking. After centrifugation (14,000 rpm, 20 s), the supernatant was transferred to a new tube, 10 g of Gq/11␣ antibody was added, and the contents were incubated for 2 h with EOE shaking. Thereafter, 100 l of prewashed agaroseprotein A/G beads (Santa Cruz Biotechnology) was added, and the contents were incubated overnight with EOE shaking. The contents were centrifuged (14,000 rpm, 1 min), the supernatant was removed, and the beads were collected. The beads were washed (14,000 rpm, 1 min), first with IP buffer and with a buffer containing 50 mM Tris·HCl, pH 8.0. To the pelleted beads, 2ϫ Laemmli buffer (50 l) was added and incubated for 1 h at 37°C. The tubes were vortexed and centrifuged (14,000 rpm, 1 min), the supernatant was collected, and bromophenol blue dye (5 l) was added and used for SDS-PAGE. Western blotting. Western blotting was performed as previously published (10) . Cell homogenates, cytosol, and membrane preparations (30 g) were resolved by SDS-PAGE on 8 -16% Trisglycine gels (Thermo Scientific) in HEPES buffer, blotted onto PVDF membrane for 3 h at 4°C, and membranes were probed with respective antibodies in 5% BSA in TBST overnight at 4°C. Imaging and quantitation of the blots were performed with FluorChem software (Protein Simple, Santa Clara, CA). The following antibodies were used: Gq/11␣ (1:500, Santa Cruz Biotechnology), Gi␣ (1:200, Cell Signaling Technology), loading control ␤-actin (1:1,000, Santa Cruz Biotechnology), D1R (1:200) and NHE3 (1:50, Millipore) and D5R (1:400, US Biological, Salem, MA).
Statistics. Data are presented as means Ϯ SE. Student's t-test and one-way ANOVA (Newman-Keuls post hoc test) were used to compare variations among the groups wherever appropriate. Statistical analysis was carried out using a software program (GraphPad Prism ver. 5; GraphPad Software, San Diego, CA). The minimum level of significance was considered at P Ͻ 0.05. S-GTP␥S binding was reduced in the Gq/11␣-depleted cells (Fig. 2, B and C) as well as in the presence of PTX (100 ng/ml) (Fig. 2, D and E 
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Effects of FD and ANG II on
Effects of FD and ANG II on PKC activity in HK2 cells.
Both FD and ANG II produced a concentration-dependent increase in the activity of PKC (Fig. 3A) . FD (10 Ϫ6 M) caused PKC stimulation to the level of a direct activator of PKC, PMA (10 Ϫ6 M), which was reduced in the presence of the D1-like receptor antagonist (SCH23390, 10 Ϫ5 M), PKC inhibitor (chelerythrine chloride, 10 Ϫ6 M), and Gi inhibitor (PTX, 100 ng/ml) (Fig. 3B) . ANG II (10 Ϫ6 M) showed a similar stimulatory response on PKC, which decreased with the AT1R blocker (candesartan, 10 Ϫ6 M), PKC inhibitor (chelerythrine chloride, 10 Ϫ6 M), and Gi inhibitor (PTX, 100 ng/ml) (Fig. 3C) . Furthermore, the FD-and ANG II-mediated increase in PKC activity was attenuated in the cells treated with Gq/11␣ siRNA but not in cells treated with control siRNA (Fig. 3D) . 
Effects of FD on cAMP accumulation and
86 Rb uptake (Na-K-ATPase activity). FD treatment caused a 2-fold while treatment with forskolin, a direct adenylate cyclase activator, resulted in 3.5-fold increases in the levels of cAMP. SCH23390 (10 Ϫ6 M) pretreatment attenuated the FD response on cAMP accumulation as well as reduced basal cAMP levels (Fig. 4A) . Furthermore, there was an ϳ50% ouabain-inhibitable 86 Rb uptake in vehicle-treated (control) cells, which decreased in FD (10 Ϫ6 M)-treated cells (Fig. 4B) . FD-mediated inhibition on 86 Rb uptake was attenuated in cells treated with SCH23390 (10 Ϫ6 M), chelerythrine chloride (10 Ϫ6 M), PTX (100 ng/ml), and Gq/11␣ siRNA (200 nM) (Fig. 4B) .
Effects of FD on Gq/11␣ and Gi␣ proteins. FD treatment of cells caused an increase in the membranous abundance of Gq/11␣ and decreased it in the cytosol (Fig. 5, A and B) . The levels of Gi␣ were not affected either in membranes or cytosol in response to FD (Fig. 6, A and B) . Furthermore, the Gq/11␣ antibody resulted in immunoprecipitation of Gq/11␣ protein and coimmunoprecipitation of Gi␣ (Fig. 7, A and B) . The levels of immunoprecipitated Gq/11␣ (Fig. 7A) 
DISCUSSION
HK2 cells, derived from adult human kidney, represent the clone of epithelial cells from proximal tubule segments (24) . These cells, despite many passages (ϳ30), are reported to retain many of the phenotypic and functional properties of the original proximal tubular cells (24) . In our study, we found that these cells also express NHE3, a sodium transporter considered to be a marker of proximal tubular epithelial cells (1, 23) . These cells offer a valuable tool for easy experimental manipulations in culture for studying the physiology/pathophysiology of renal epithelial cells derived from proximal tubule segments.
A recent study (13) , however, reported that these cells harbor a nonfunctional dopamine D1 receptor, questioning their use as a renal cell model for the study of dopamine D1 receptor signaling mechanisms. This was inferred based upon the inability of FD to activate adenylate cyclase and inhibit the sodium transporter Na/H exchanger in these cells (13) . D1R, when it couples to Gs protein, activates adenylate cyclase and transduces the downstream signal for the inhibition of the Na/H exchanger (5, 16, 26) . However, when it couples to Gq protein, it triggers the PKC-mediated downstream signal for inhibition of another sodium transporter, Na-K-ATPase (6, 11, 12, 18, 27 ). In the above study, FD (a D1-like receptor agonist) failed to inhibit Na/H exchanger activity but caused inhibition of Na-K-ATPase (13) . This suggests that D1R-Gq coupling and signaling is normal in HK2 cells. We became interested in exploring this pathway in HK2 cells.
We found that FD in these cells stimulates PKC activity and causes inhibition of Na-K-ATPase activity as determined by 86 Rb uptake assay. They also seem to possess almost 50% ouabain-inhibitable 86 rubidium transport activity or Na-KATPase activity, which decreased in response to FD. Furthermore, the FD response on PKC and Na-K-ATPase in these cells requires coupling of D1R with not only Gq/11␣ but also Gi as the effect was ablated in the presence of Gq/11␣ siRNA and the Gi inhibitor PTX, respectively. The interaction between D1R and Gq/11␣ is not new (11, 12, 26, 28) ; however, the finding that D1R also interacts with Gi in renal cells is novel. Perhaps both Gq/11␣ and Gi form a heterodimer, as they coimmunoprecipitated in our study, for D1R downstream signaling in response to FD. A switch in D1R signaling from Gs to Gi, requiring one or the other, is reported in undifferentiated HEK cells overexpressing D1R and the histamine-3 receptor (8) . Our data are different from the above study, demonstrating that in differentiated HK2 cells endogenous D1R signaling requires both Gq/11␣ and Gi proteins. The reason for the involvement of both the G proteins subunits (Gq11␣ and Gi) for D1R signaling in HK2 cells is not known and warrants future investigation. Also, which D1-like receptor subtypes, D1R vs. D5R, is involved in this process is not known. It is perhaps the D1R which drives the FD response in HK2 cells as D1R but not D5R couples to Gq (4) and D1R is the predominant receptor subtype expressed in these cells (Fig. 1A) . A careful study design depleting D1R and D5R sequentially by an siRNA approach will, however, address the receptor subtype issue in this process, which needs to be determined.
The discrepancy with regard to D1R signaling in HK2 cells between our study (intact D1R signaling) and the study (defective D1R signaling) by Gildea et al. (13) may well be due to mutation in HK2 cells. Cell lines could mutate and may give rise to different study outcome. For example, the findings of Gildea et al. (13) in HK2 cells related to the inability of FD to increase cAMP accumulation was not corroborated either by the findings of Zhang and Yuan (30) or by our present study (Fig. 4A) . We found that D1R activation increases cAMP accumulation, which is in agreement with the study by Zhang and Yuan (30) . In addition, D1-like receptor antagonist SCH23390 pretreatment attenuated the FD response on cAMP accumulation as well as reduced basal cAMP levels in HK2 cells. These studies suggest that it is not only a D1R-specific event but it also involves in the maintenance of basal levels of an important second messenger, cAMP. The discrepancy with regard to FD-mediated cAMP accumulation in the study by Gildea et al. (13) may well be due to a mutation in HK2 cells used by these authors (13) . Taken together, these results suggest that HK2 cells not only have an intact D1R coupling to Gs (based on cAMP data) but also exhibit a novel D1R signaling mechanism requiring both Gq11␣ and Gi.
Conclusions. Our study clearly demonstrates that HK2 cells harbor a functional D1R and is a suitable renal cell model for studying mechanistic aspect of D1R physiology. Since the source of HK2 cells is human, the result-outcome from studying these cells over nonhuman renal cells has potential translational values.
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